| Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery P Desai, RR Patlolla, M Singh Molecular membrane biology 27 (7), 247-259, 2010 | 478 | 2010 |
| Structure-activity relationship of chemical penetration enhan-cers in transdermal drug delivery N Kanikkannan, K Kandimalla, SS Lamba, M Singh Current medicinal chemistry 7 (6), 593-608, 2000 | 427 | 2000 |
| Factors affecting microencapsulation of drugs in liposomes SB Kulkarni, GV Betageri, M Singh Journal of microencapsulation 12 (3), 229-246, 1995 | 338 | 1995 |
| Lipophilic drug derivatives in liposomes M Gulati, M Grover, S Singh, M Singh International journal of pharmaceutics 165 (2), 129-168, 1998 | 335 | 1998 |
| Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products P Pandi, R Bulusu, N Kommineni, W Khan, M Singh International journal of pharmaceutics 586, 119560, 2020 | 319 | 2020 |
| Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers RR Patlolla, M Chougule, AR Patel, T Jackson, PNV Tata, M Singh Journal of Controlled Release 144 (2), 233-241, 2010 | 300 | 2010 |
| Transferrin as a targeting ligand for liposomes and anticancer drugs M Singh Current pharmaceutical design 5 (6), 443-452, 1999 | 285 | 1999 |
| AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies C Godugu, AR Patel, U Desai, T Andey, A Sams, M Singh PloS one 8 (1), e53708, 2013 | 281 | 2013 |
| Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs PP Shah, PR Desai, AR Patel, MS Singh Biomaterials 33 (5), 1607-1617, 2012 | 253 | 2012 |
| Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo PR Desai, S Marepally, AR Patel, C Voshavar, A Chaudhuri, M Singh Journal of controlled release 170 (1), 51-63, 2013 | 205 | 2013 |
| Nuclear receptor 4A (NR4A) family–orphans no more S Safe, UH Jin, B Morpurgo, A Abudayyeh, M Singh, RB Tjalkens The Journal of steroid biochemistry and molecular biology 157, 48-60, 2016 | 203 | 2016 |
| Skin permeation enhancement effect and skin irritation of saturated fatty alcohols N Kanikkannan, M Singh International journal of pharmaceutics 248 (1-2), 219-228, 2002 | 185 | 2002 |
| Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid C Godugu, AR Patel, R Doddapaneni, J Somagoni, M Singh PloS one 9 (3), e89919, 2014 | 157 | 2014 |
| Characterization and printability of Sodium alginate-Gelatin hydrogel for bioprinting NSCLC co-culture A Mondal, A Gebeyehu, M Miranda, D Bahadur, N Patel, S Ramakrishnan, ... Scientific reports 9 (1), 19914, 2019 | 152 | 2019 |
| Evaluation of different parameters that affect droplet‐size distribution from nasal sprays using the Malvern Spraytec® P Dayal, MS Shaik, M Singh Journal of pharmaceutical sciences 93 (7), 1725-1742, 2004 | 150 | 2004 |
| Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer M Chougule, AR Patel, P Sachdeva, T Jackson, M Singh Lung cancer 71 (3), 271-282, 2011 | 146 | 2011 |
| Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non–small cell lung cancer N Ichite, MB Chougule, T Jackson, SV Fulzele, S Safe, M Singh Clinical Cancer Research 15 (2), 543-552, 2009 | 144 | 2009 |
| Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin S Andega, N Kanikkannan, M Singh Journal of controlled release 77 (1-2), 17-25, 2001 | 142 | 2001 |
| Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer MB Chougule, AR Patel, T Jackson, M Singh PloS one 6 (3), e17733, 2011 | 138 | 2011 |
| The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53 SO Lee, T Andey, UH Jin, K Kim, M Sachdeva, S Safe Oncogene 31 (27), 3265-3276, 2012 | 134 | 2012 |
